Sharing NYSCF’s Voice on Big Data, Precision Medicine and Innovative Business Models
NYSCF CEO Susan L. Solomon discussed “Harnessing patient data using stem cells to power precision medicine” during her co-located keynote plenary talk at the Cord Blood World Europe, World Advanced Therapies & Regenerative Medicine Congress 2017, and the World Precision Medicine Congress 2017 conferences in London, UK. Following the plenary discussion, Ms. Solomon joined a panel to explore “The Future of Medicine: A Conversation” with Dr. Ian Campbell, Director for Health and Life Sciences, Innovate UK; Dr. Joanne Kurtzberg, Director, Carolinas Cord Blood Bank, Duke University; and Dr. Patrick Keohane, Chief Medical Officer, BenevolentAI.
The annual New York BIO conference in Manhattan also featured Ms. Solomon on a panel exploring the success of “Research Foundations with Innovative Business Models in New York” alongside Annette Bakker of the Children’s Tumor Foundation, Michael Batten of the T1D Fund and JDRF, Sohini Chowdhury of The Michael J. Fox Foundation for Parkinson’s Research, Lara Sullivan of Pfizer, and the New York City Economic Development Corporation.